Quote:
Monday, August 14, 2006 8:12:39 AM ET
Dow Jones Newswires
1101 GMT [Dow Jones]--Synthes (SYST.VX) on Wednesday is expected to post a 15% rise in 1H net profit to $257.3M from $224.5M, according to an average of 5 analysts forecasts polled by Dow Jones Newswires. The rise in net profit is driven by a 13% increase in 1H sales to $1.16B from last year's $1.03B, due to further product rollouts, expansion of its sales force and solid underlying growth of the spine and trauma markets. EBIT is seen at $394M, up from $357.1M. Analysts will eye gross profit margin development, any update on the pending FDA approval for its artificial disc ProDisc and comments about the royalty deal with the AO foundation. Trades -0.2% at CHF141.60. (SWZ)
|
Just a news trickle....
__________________
12/16/03 Work Accident
Herniation and DDD at L4-L5
4/1/05 Discectomy
Epidurals and facet injections
5/15/06 Discogram confirmed L4-L5 DDD also an asymptomatic L5-S1 tear
10/24/06 L4-L5 Prodisc surgery with Dr. Goldstein
CAT scans & X-Rays show ossification
Trigger Point Injections, Medial Branch Blocks, Acupuncture, Weekly Deep Tissue Massage
10/27/08 Discogram (positive L5-S1 tear) 
11/25/08 L5-S1 fusion with Dr. Goldstein
FAILED BACK SYNDROME
Liberty Mutual WC
|